S&CO Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.69M | Buy |
104,837
+264
| +0.3% | +$21.9K | 0.56% | 46 |
|
|
2025
Q1 | $8.48M | Sell |
104,573
-34,802
| -25% | -$2.82M | 0.57% | 44 |
|
|
2024
Q4 | $12.6M | Sell |
139,375
-25,500
| -15% | -$2.3M | 0.85% | 31 |
|
|
2024
Q3 | $16.3M | Buy |
164,875
+1,400
| +0.9% | +$138K | 1.06% | 27 |
|
|
2024
Q2 | $15.2M | Buy |
163,475
+525
| +0.3% | +$48.7K | 1.06% | 27 |
|
|
2024
Q1 | $15.5M | Sell |
162,950
-4,492
| -3% | -$426K | 1.09% | 25 |
|
|
2023
Q4 | $15M | Sell |
167,442
-1,575
| -0.9% | -$141K | 1.15% | 25 |
|
|
2023
Q3 | $12.3M | Buy |
169,017
+35
| +0% | +$2.56K | 1.01% | 29 |
|
|
2023
Q2 | $14.1M | Buy |
168,982
+148,110
| +710% | +$12.3M | 1.13% | 27 |
|
|
2023
Q1 | $1.59M | Buy |
20,872
+16,415
| +368% | +$1.25M | 0.14% | 95 |
|
|
2022
Q4 | $369K | Buy |
4,457
+600
| +16% | +$49.7K | 0.03% | 145 |
|
|
2022
Q3 | $305K | Buy |
3,857
+30
| +0.8% | +$2.37K | 0.03% | 157 |
|
|
2022
Q2 | $284K | Buy |
+3,827
| New | +$284K | 0.02% | 162 |
|